HNGE:NYSEHinge Health, Inc. analysis
Data as of Aug 28, 2026 - not real-time
- Latest price
- $87.35
- Risk: medium
- 7/10Medium risk
Summary
The moving-average structure behind Hinge Health, Inc. is bullish at $87.35, with short-term averages leading the long-term ones. Relative strength is 53.2 — neutral — and the MACD signal is bearish. Watch $75.19 as support and $95.57 as the nearer resistance level.
Multiples put this in undervalued territory: 10.6 times earnings against the sector's 30.5. Analyst price targets sit 21.9% above the current price. Revenue is growing at 53.0% on a 15.1% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 52.9%, a beta of 1.10 and a maximum drawdown of 48.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.
Multiples put this in undervalued territory: 10.6 times earnings against the sector's 30.5. Analyst price targets sit 21.9% above the current price. Revenue is growing at 53.0% on a 15.1% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 52.9%, a beta of 1.10 and a maximum drawdown of 48.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.
Top market events
- Hinge Health Inc. HNGE delivered earnings and revenue surprises of 0.00% and +6.14%, respectively, for the quarter...
- Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Small...
- On August 4, Hinge Health NASDAQ:HNGE delivered a quarter that beat its own guidance on nearly every line, then turned...
Market outlook
Short term
< 1 yearPositive
Model confidence6/106 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 55.55
- MACD momentum is negative
Medium term
1–3 yearsPositive
Model confidence6/106 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- P/E of 10.6 versus sector average of 30.5
- Trading above the 200-day average of 55.55
Long term
> 3 yearsPositive
Model confidence7/107 out of 10
Key factors
- P/E of 10.6 versus sector average of 30.5
- Analyst targets imply +21.9% versus the current price
- Profit margin of 15.1% is healthy
Key metrics
Financial health
Revenue Growth53.00%
Profit Margin15.15%
P/E Ratio10.6
ROE30.38%
ROA7.70%
Debt/Equity1.71
P/B Ratio20.3
Op. Cash Flow$290.8M
Free Cash Flow$299.6M
Industry P/E30.5
Technical analysis
TrendBullish
RSI53.2
Support$75.19
Resistance$95.57
MA 20$86.96
MA 50$83.31
MA 200$55.55
MACDBearish
VolumeDecreasing
Fear & Greed Index95.66
Valuation
Fair Value$134.83
Target Price$106.47
Upside/Downside21.89%
GradeUndervalued
TypeGrowth
Risk assessment
Beta1.10
Volatility52.87%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.